Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed.
Saved in:
| Title: | Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed. |
|---|---|
| Authors: | Rustin, G. J. S.1 grustin@nhs.net |
| Source: | Annals of Oncology. 2011 Suppl. 8, Vol. 22, pviii45-viii48. 4p. 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdr471 |
